This report provides a comprehensive analysis of the business environment, focusing on the operations of AstraZeneca. It begins by defining business and its environment, then explores different organizational structures including public, private, and voluntary sectors, and their respective advantages and disadvantages. The report delves into the legal structures within the private sector, such as sole traders, partnerships, and limited companies, with specific reference to AstraZeneca's structure. It examines organizational size, scope, and how these align with business objectives. The complexities of various business structures, including hierarchical, functional, divisional, and hybrid models, are discussed, alongside the interrelationships between different organizational functions like IT, HR, production, and finance. The report also assesses the macro environment's impact on AstraZeneca, incorporates a SWOT analysis, and suggests actions for firm growth. Overall, the report offers a detailed understanding of the business environment and its implications for AstraZeneca's success.